Cargando…

Survival Trends in Gastric Adenocarcinoma: A Population-Based Study in Sweden

BACKGROUND: Gastric adenocarcinoma is the second most common cancer-related death globally. Assessing survival trends can help evaluate changes in detection and treatment. We aimed to determine recent prognosis trends in gastric non-cardia and cardia adenocarcinoma in an unselected cohort with compl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asplund, Johannes, Kauppila, Joonas H., Mattsson, Fredrik, Lagergren, Jesper
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Gastrointestinal Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097732/ https://www.ncbi.nlm.nih.gov/pubmed/29987609 http://dx.doi.org/10.1245/s10434-018-6627-y

Ejemplares similares

Aspirin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma
por: Holmberg, Dag, et al.
Publicado: (2022)

Impact of Age on the Treatment and Survival in Esophagogastric Cancer
por: Kauppila, Joonas H., et al.
Publicado: (2023)

ASO Author Reflections: Survival Trends in Gastric Adenocarcinoma
por: Asplund, Johannes, et al.
Publicado: (2018)

Marital status and survival after oesophageal cancer surgery: a population-based nationwide cohort study in Sweden
por: Brusselaers, Nele, et al.
Publicado: (2014)

Correction: Diverging Trends in Recent Population-Based Survival Rates in Oesophageal and Gastric Cancer
por: Lagergren, Jesper, et al.
Publicado: (2012)

Prognosis of oesophageal adenocarcinoma and squamous cell carcinoma following surgery and no surgery in a nationwide Swedish cohort study
por: Kauppila, Joonas H, et al.
Publicado: (2018)

ASO Author Reflections: Increasing Age is Associated with Increased Risk of Long-Term Mortality After Surgery and Non-operation in Esophagogastric Cancer Patients
por: Kauppila, Joonas H., et al.
Publicado: (2023)

Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma
por: Moore, Jonathan L., et al.
Publicado: (2023)

Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population
por: Moore, J. L., et al.
Publicado: (2022)

Surgeon Volume and Surgeon Age in Relation to Proficiency Gain Curves for Prognosis Following Surgery for Esophageal Cancer
por: Gottlieb-Vedi, Eivind, et al.
Publicado: (2018)

Diverging Trends in Recent Population-Based Survival Rates in Oesophageal and Gastric Cancer
por: Lagergren, Jesper, et al.
Publicado: (2012)

Outcome of Patients Treated Within and Outside a Randomized Clinical Trial on Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: Extrapolation of a Randomized Clinical Trial (CROSS)
por: Toxopeus, Eelke, et al.
Publicado: (2018)

Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden
por: Brusselaers, Nele, et al.
Publicado: (2017)

Life Expectancy in Survivors of Esophageal Cancer Compared with the Background Population
por: Lundberg, Ellinor, et al.
Publicado: (2022)

Prognostic Significance of Lymphatic, Venous and Perineural Invasion After Neoadjuvant Chemotherapy in Patients with Gastric Adenocarcinoma
por: Woodham, Benjamin L., et al.
Publicado: (2020)

Population-Based Study on Risk Factors for Tumor-Positive Resection Margins in Patients with Gastric Cancer
por: van der Werf, Leonie R., et al.
Publicado: (2019)

Analysis of the Survival Impact of Postoperative Chemotherapy After Preoperative Chemotherapy and Resection for Gastric Cancer
por: Drake, Justin A., et al.
Publicado: (2020)

Bariatric surgery volume by hospital and long-term survival: population-based NordOSCo data
por: Markar, Sheraz R, et al.
Publicado: (2022)

Survival trends in gastric cancer patients between 1987 and 2016: a population-based cohort study in Finland
por: Maharjan, Urgena, et al.
Publicado: (2022)

Heterogeneity and Adjuvant Therapeutic Approaches in MSI-H/dMMR Resectable Gastric Cancer: Emerging Trends in Immunotherapy
por: Wu, Hui, et al.
Publicado: (2023)

Surgery for Gastric Remnant Cancer Results in Similar Overall Survival Rates Compared with Primary Gastric Cancer: A Propensity Score-Matched Analysis
por: Galata, Christian, et al.
Publicado: (2020)

Causes of death in patients diagnosed with gastric adenocarcinoma in Sweden, 1970‐2014: A population‐based study
por: Xie, Shao‐Hua, et al.
Publicado: (2020)

Impact of Surgical Margins on Overall Survival after Gastrectomy for Gastric Cancer: A Validation of Japanese Gastric Cancer Association Guidelines on a Western Series
por: Maspero, Marianna, et al.
Publicado: (2022)

Health-related quality of life after gastrectomy, esophagectomy, and combined esophagogastrectomy for gastroesophageal junction adenocarcinoma
por: Kauppila, Joonas H., et al.
Publicado: (2017)

Gastrectomy compared to oesophagectomy for Siewert II and III gastro-oesophageal junctional cancer in relation to resection margins, lymphadenectomy and survival
por: Kauppila, Joonas H., et al.
Publicado: (2017)

Impact of Laparoscopic Gastrectomy on the Completion Rate of the Perioperative Chemotherapy Regimen in Gastric Cancer: A Swedish Nationwide Study
por: Tsekrekos, Andrianos, et al.
Publicado: (2023)

Survival Benefit of Neoadjuvant Chemotherapy with S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis
por: Kano, Masayuki, et al.
Publicado: (2019)

A High Lymph Node Yield is Associated with Prolonged Survival in Elderly Patients Undergoing Curative Gastrectomy for Cancer: A Dutch Population-Based Cohort Study
por: Brenkman, Hylke J. F., et al.
Publicado: (2017)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial
por: Yang, Xiao-Jun, et al.
Publicado: (2011)

Discordant nodal staging identifies intermediate-risk group for overall survival in patients with cT3 oesophageal adenocarcinoma
por: Carder, Charles, et al.
Publicado: (2020)

Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma
por: Goense, Lucas, et al.
Publicado: (2018)

Association Among Blood Transfusion, Postoperative Infectious Complications, and Cancer-Specific Survival in Patients with Stage II/III Gastric Cancer After Radical Gastrectomy: Emphasizing Benefit from Adjuvant Chemotherapy
por: Xiao, Hua, et al.
Publicado: (2020)

Population-Based Study of Islet Cell Carcinoma
por: Yao, James C., et al.
Publicado: (2007)

Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma
por: Anderegg, M. C. J., et al.
Publicado: (2017)

Targeting Gastric Cancer with Trastuzumab: New Clinical Practice and Innovative Developments to Overcome Resistance
por: Roukos, Dimitrios H.
Publicado: (2009)

More Controversy than Ever – Challenges and Promises Towards Personalized Treatment of Gastric Cancer
por: Liakakos, Theodore, et al.
Publicado: (2008)

Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis
por: Meijer, Laura L., et al.
Publicado: (2018)

Leveraging the Multidisciplinary Tumor Board for Dissemination of Evidence-Based Recommendations on the Staging and Treatment of Gastric Cancer: A Pilot Study
por: Mehta, Shivani N., et al.
Publicado: (2022)

Is Lymphadenectomy a Predictor or Savior for Patients with Gastric Cancer?
por: Takeuchi, Hiroya, et al.
Publicado: (2010)

The Role of Endoscopy in the Diagnosis of Gastric Gastrointestinal Stromal Tumors
por: Nishida, Toshirou
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6jcd5qpbmj3gbkq0e48cqn2cif